Siemens, BioNTech to Expand Vaccine Production Collaboration
June 23 2021 - 10:25AM
Dow Jones News
By Cecilia Butini
Siemens AG said Wednesday that it is expanding its cooperation
with German pharmaceutical company BioNTech SE on production
capacity for Covid-19 vaccines.
"Within this cooperation, Siemens will provide the latest
automation and digitalization technologies for BioNTech production
sites, such as design, simulation, and engineering software as well
as process control technology," the German company said.
BioNTech previously said that it would establish new production
sites for vaccine production worldwide, starting with a new
production facility in Singapore. The pharmaceutical company has
also converted an existing plant in Marburg, Germany into a vaccine
production facility using support from Siemens, Siemens said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
June 23, 2021 10:20 ET (14:20 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Sep 2023 to Sep 2024